Dr. Adam Burgoyne is an Associate Clinical Professor of Medicine in the Division of Hematology/Oncology at the UC San Diego Moores Cancer Center. He is a board-certified medical oncologist specializing in the treatment of gastrointestinal and hepatobiliary tumors. He received his medical and graduate degrees from Case Western Reserve University School of Medicine and completed his internal medicine residency and hematology/oncology fellowship at UC San Diego Medical Center, where he served as Chief Fellow. His clinical practice at the Moores Cancer Center is primarily dedicated to the care of patients with hepatobiliary malignancies (hepatocellular carcinoma and biliary tract cancers) and gastrointestinal stromal tumors, where he co-leads the multidisciplinary primary liver cancer clinic and serves as co-leader of the gastrointestinal cancer disease team. He is a physician-scientist with a translational science focus on the identification of molecular biomarkers of response to targeted therapies in hepatocellular carcinoma using bioinformatic and patient-derived tumor models. He is active in clinical research and is the principal investigator of both sponsored and investigator-initiated clinical trials for patients with hepatobiliary malignancies and gastrointestinal stromal tumors.